Skip to main content

Advertisement

Table 4 Metabolites with significant difference among groups during the validation stage

From: Serum metabolic biomarkers distinguish metabolically healthy peripherally obese from unhealthy centrally obese individuals

Metabolites (umol/L) NM MUCO MHPO P1 P2 P3
Leucine 189.5 ± 37.6 321.5 ± 36.8 216.6 ± 32.6 0.000 0.346 0.000
Isoleucine 87.7 ± 48.2 132.0 ± 52.7 92.5 ± 45.2 0.000 0.584 0.000
Valine 297.8 ± 50.1 388.5 ± 53.4 291.3 ± 43.4 0.000 0.917 0.000
alphaAAA 2.45 ± 0.24 3.10 ± 0.40 2.62 ± 0.29 0.000 0.138 0.000
C3 0.30 ± 0.08 0.42 ± 0.11 0.29 ± 0.11 0.000 0.976 0.000
  1. All values are means ± SDs. The One-Way ANOVA followed by Tukey test was set to p < 0.05. NW normal weight, MUCO metabolically unhealthy central obesity, MHPO metabolically healthy peripheral obesity; alphaAAA, alpha-aminoadipic acid. Logarithmic transformation was used for the variables that did not have normal distribution (alphaAAA); P1: The P value between MUCO and NW groups; P2: The P value between MHPO and NW groups; P3:The P value between MUPO and MHPO groups